Blue Matter Blog

Recap:  Psychedelic Therapeutics and Drug Development Conference
May 25, 2021

Introduction Members of Blue Matter’s CNS team attended the Psychedelic Therapeutics & Drug Development Conference, a virtual event that took place May 4-6, 2021.  This event was particularly interesting to our team because we had just completed a white paper entitled “Taboo” Substances are Getting Another Look in CNS that explored the substances and companies …

American Academy of Neurology (AAN) 2021: Annual Meeting Recap
May 24, 2021

Introduction Members of our CNS team attended the American Academy of Neurology (AAN) virtual annual meeting, which took place April 17-22. As expected, it was an interesting and useful event, full of industry therapeutics updates, clinical research data, scientific sessions, and educational courses presented in a series of virtual panels, posters, and fireside chats.  It …

Key Themes from the 2021 Virtual World Orphan Drug Congress
May 3, 2021

Some of our Rare Disease team spent a day last week listening to patient experts and industry specialists in a series of virtual panels and fireside chats organized by the World Orphan Drug Congress. Amongst a wealth of interesting topics and a consistent focus on accelerating the delivery of rare disease (RD) therapies, a few …